The Loss of <i>SMAD4/DPC4</i> Expression Associated with a Strongly Activated Hedgehog Signaling Pathway Predicts Poor Prognosis in Resected Pancreatic Cancer.

J Cancer · 2019 · PMC6692626 · PMID 31417657

Europe PMC DOI

hedged sentence

0.0740

closest p · 1.5× alpha

0.0740

boldest claim

The sentences

borderline significantp = 0.074so close (0.05 < p ≤ 0.1)

Our results showed that loss of Smad4 immunolabeling was an independent prognostic factor for shorter OS (HR 1.551, p = 0.045) and a borderline significant prognostic factor for shorter RFS (HR 2.045, p = 0.074).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.